Icon

RELEXXII (nda216117)- (18MG,27MG,36MG,45MG,54MG,63MG,72MG)

METHYLPHENIDATE HYDROCHLORIDE OSMOTICA PHARM US
18MG,27MG,36MG,45MG,54MG,63MG,72MG
No No
2037-Feb-03 Expired
None None
None No
RELEXXII® is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults (up to the age of 65 years) and pediatric patients 6 years of age and older.
0 0 0
Total Other Developers None
Drugs with Suitability No
18MG ** ** - - -
27MG ** ** - - -
36MG ** ** - - -
45MG ** ** - - -
54MG ** ** - - -
63MG ** ** - - -
72MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.